Antibodies & Hybridomas — page 43 of 137
Antibodies & Hybridomas
Page 43 of 137
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 Spike | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
 ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 200 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | CR3022 | n/a | SARS coronavirus (SARS-CoV-2) | unconjugated | 100 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | 5E12 | Mouse | SARS coronavirus (SARS-CoV-2) | unconjugated | 100 µg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | polyclonal | Rabbit | SARS CoV-2 alpha, SARS coronavirus-2 (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike | 15D9-E2-C10 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
| SARS-CoV-2 Spike glycoprotein (Sotrovimab (VIR-7831/GSK4182136) biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
 ABBEXA LTD |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Mouse | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
 CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 RBD | monoclonal | Recombinant Human | n/a | unconjugated | 0.1 mg | n/a |
 BIORBYT LTD. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV, SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Recombinant Mouse | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Recombinant Mouse | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Recombinant Mouse | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |